EBMT 2019 | Regulatory and commercialization challenges with CAR T-cell therapy

Name: Regulatory and commercialization challenges with CAR T-cell therapy
Uploaded: 2019-04-05T15:35:55.000Z
Duration: 1 min 51 s
Description: Bruce Levine, PhD, from the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, discusses the challenges regarding regulatory and commercialization of CAR T-cell therapy. Dr Levine was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

Bruce Levine • 5 Apr 2019

EBMT 2019

General CAR-T

Bruce Levine, PhD, from the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, discusses the challenges regarding regulatory and commercialization of CAR T-cell therapy. Dr Levine was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.